Levi & Korsinsky Reminds Voyager Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - VYGR
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Voyager Therapeutics, Inc. (NASDAQ: VYGR) for potential violations of federal securities laws. This follows Voyager's announcement about assessing alternate payloads for its gene therapy program due to concerns over the siRNA payload component of VY9323.
February 21, 2025 | 4:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Voyager Therapeutics is under investigation for potential securities law violations after announcing issues with its gene therapy program. This could impact investor confidence and stock price.
The investigation into potential securities law violations is significant as it may lead to legal consequences and affect investor trust. The announcement of issues with the gene therapy program could further impact the stock negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100